coin-img-ETHETH+1.08%coin-img-BTCBTC+0.69%coin-img-SOLSOL+1.33%coin-img-USDCUSDC-0.01%coin-img-UBOXUBOX-59.45%coin-img-XRPXRP+0.99%coin-img-HYPEHYPE-2.89%coin-img-TRXTRX+0.52%coin-img-ETHETH+1.08%coin-img-BTCBTC+0.69%coin-img-SOLSOL+1.33%coin-img-USDCUSDC-0.01%coin-img-UBOXUBOX-59.45%coin-img-XRPXRP+0.99%coin-img-HYPEHYPE-2.89%coin-img-TRXTRX+0.52%coin-img-ETHETH+1.08%coin-img-BTCBTC+0.69%coin-img-SOLSOL+1.33%coin-img-USDCUSDC-0.01%coin-img-UBOXUBOX-59.45%coin-img-XRPXRP+0.99%coin-img-HYPEHYPE-2.89%coin-img-TRXTRX+0.52%coin-img-ETHETH+1.08%coin-img-BTCBTC+0.69%coin-img-SOLSOL+1.33%coin-img-USDCUSDC-0.01%coin-img-UBOXUBOX-59.45%coin-img-XRPXRP+0.99%coin-img-HYPEHYPE-2.89%coin-img-TRXTRX+0.52%
user-avatar
Reuters

Cigna lifts 2026 adjusted profit outlook to at least $30.45 a share as Evernorth revenue rises 6%

AI Market Summary
Cigna's Q2 results showed continued strength in Evernorth Health Services, with adjusted segment revenue up 6% and EPS beating consensus, supporting confidence in its earnings durability despite a higher medical loss ratio. Management also raised its 2026 adjusted EPS outlook modestly, reinforcing the strategic pivot away from government-backed plans toward employer-sponsored and pharmacy benefit management. The update is likely supportive for managed-care and PBM-related equities near term.
Impact level
● Medium
Affected assets
NCSKCIEN2USD/USDT+5.06%
AI Insight · NCSKCIEN2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Cigna reported second-quarter 2024 results showing adjusted revenue at its Evernorth Health Services unit of $61.47 billion, up 6% year over year, alongside a medical loss ratio of 84.5%, up 1.3 percentage points. Adjusted earnings were $7.78 per share, above the $7.60 consensus estimate. The company also raised its 2026 adjusted earnings forecast by 10 cents to at least $30.45 per share. The results reflect steady growth in its core health services business.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.